Vast Therapeutics
PrivateLast Round
Grant
Sep 16, 2025
Est. Valuation
$49.85M
Total Funding Raised
$35.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vast Therapeutics is a clinical-stage life sciences company that develops nitric oxide-based medicines for patients with chronic respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vast Therapeutics Comparables
Compare Vast Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novoteris, LLC | 88% | |
| Matinas BioPharma Holdings, Inc. | 70% | |
| Insmed Incorporated | 69% | |
Vast Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 16, 2025 | ||||
| Series B | Mar 17, 2025 | ||||
| Grant | Jan 21, 2025 | ||||
| Grant | Jan 16, 2019 | ||||
| Series A | Jan 16, 2019 | ||||
Grant | Dec 13, 2018 |
Vast Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shionogi & Co. | Series A |
| NIH RADx | Grant |
| Cystic Fibrosis Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
Secured $2M from NIH RADx.
- Mar 17, 2025
$590K round with Charles Swoboda and KNOW Bio
Vast Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vast Therapeutics's valuation, stock price, and market status.